Skip to main content

Research Repository

Advanced Search

Dual roles of demethylation in cancer treatment and cardio-function recovery

Li, Xinuo; Shen, Dehong; Zhu, Zheying; Lyu, Dayin; He, Chang; Sun, Yuan; Li, Jinran; Lu, Qiulun; Wang, Guangji

Dual roles of demethylation in cancer treatment and cardio-function recovery Thumbnail


Authors

Xinuo Li

Dehong Shen

ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
Associate Professor in International Pharmacy and Traditional Medicines

Dayin Lyu

Chang He

Yuan Sun

Jinran Li

Qiulun Lu

Guangji Wang



Abstract

There are no effective therapeutic targets or strategies that simultaneously inhibit tumour growth and promote cardiac function recovery. Here, we analyzed targets for cancer treatments and cardiac repair, with demethylation emerging as a common factor in these candidate lists. As DNA methyltransferase 1 (DNMT1) majorly responds to methylation, a natural compound library is screened, identifying dioscin as a novel agent targeted at DNMT1, widely used for heart diseases. Dioscin was found to reduce DNMT activities and inhibits growth in breast cancer cells. Combined with analyses of RNA-seq and MeDIP-seq, the promoters of antioxidant genes were demethylated after dioscin, recruiting NRF2 and elevating their expression. In Nrf2 knockout mice, the cardiac protection role of dioscin was blocked by Nrf2-loss. Furthermore, in tumour-bearing mice with hypertrophy, dioscin was observed to inhibit tumour growth and alleviate cardiac injury simultaneously. This study is the first to identify dioscin as a novel demethylation agent with dual functions of anti-cancer and cardio-protection.

Citation

Li, X., Shen, D., Zhu, Z., Lyu, D., He, C., Sun, Y., …Wang, G. (2023). Dual roles of demethylation in cancer treatment and cardio-function recovery. Redox Biology, 64, Article 102785. https://doi.org/10.1016/j.redox.2023.102785

Journal Article Type Article
Acceptance Date Jun 13, 2023
Online Publication Date Jun 14, 2023
Publication Date 2023-08
Deposit Date Jun 24, 2023
Publicly Available Date Jun 30, 2023
Journal Redox Biology
Print ISSN 2213-2317
Electronic ISSN 2213-2317
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 64
Article Number 102785
DOI https://doi.org/10.1016/j.redox.2023.102785
Keywords DNMT inhibitors; Demethylation; NRF2; Hypertrophy; Cancer treatment
Public URL https://nottingham-repository.worktribe.com/output/22203613
Publisher URL https://www.sciencedirect.com/science/article/pii/S2213231723001866?via%3Dihub

Files





You might also like



Downloadable Citations